NYSE
USD
AbbVie Inc. (ABBV)
256.46
-3.75
(-1.44%)
At close: September 4 at 4:03:55 PM EDT
260.72
+4.26
(+1.66%)
After hours: September 4 at 7:59:03 PM EDT
Trade AbbVie on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutAbbVie is focusing on its oncology pipeline with promising results from its myeloma drug etentamig, which shows a 74% response rate. However, the company faces challenges from declining Humira sales and increasing competition, while analysts project strong revenue growth in 2026.
